Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease
Authors
Keywords
Chronic Obstructive Pulmonary Disease, Etanercept, Chronic Obstructive Pulmonary Disease Patient, Abatacept, Ustekinumab
Journal
DRUGS
Volume 76, Issue 13, Pages 1257-1270
Publisher
Springer Nature
Online
2016-08-09
DOI
10.1007/s40265-016-0625-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases
- (2016) George E. Fragoulis et al. Annual Review of Medicine
- Mepolizumab in COPD with Eosinophilic Bronchitis: A Randomized Clinical Trial
- (2016) Parameswaran K. Nair et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Update on molecular mechanisms of corticosteroid resistance in chronic obstructive pulmonary disease
- (2016) Zhilong Jiang et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- IL-17 in Chronic Inflammation: From Discovery to Targeting
- (2016) Audrey Beringer et al. TRENDS IN MOLECULAR MEDICINE
- Targeting the IL-33/IL-13 Axis for Respiratory Viral Infections
- (2016) Chantal Donovan et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Increased IL-33 expression in chronic obstructive pulmonary disease
- (2015) Jie Xia et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
- (2015) Abraham B. Roos et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mild Chronic Obstructive Pulmonary Disease Does Exist—and Affects Gas Exchange during Exercise
- (2015) Peter Calverley AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke–induced Lymphoid Neogenesis
- (2015) Abraham B. Roos et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Asthma–COPD Overlap. Clinical Relevance of Genomic Signatures of Type 2 Inflammation in Chronic Obstructive Pulmonary Disease
- (2015) Stephanie A. Christenson et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Transforming Growth Factor-β Superfamily in Obstructive Lung Diseases. More Suspects Than TGF-β Alone
- (2015) Fien M. Verhamme et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Interleukin-33 promotes inflammatory cytokine production in chronic airway inflammation
- (2015) Jin Shang et al. Biochemistry and Cell Biology
- Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma
- (2015) PD Mitchell et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- PA401, a novel CXCL8-based biologic therapeutic with increased glycosaminoglycan binding, reduces bronchoalveolar lavage neutrophils and systemic inflammatory markers in a murine model of LPS-induced lung inflammation
- (2015) Tiziana Adage et al. CYTOKINE
- Strategies targeting the IL-4/IL-13 axes in disease
- (2015) Richard D. May et al. CYTOKINE
- Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation
- (2015) Ari B. Molofsky et al. IMMUNITY
- Therapeutic approaches to asthma–chronic obstructive pulmonary disease overlap syndromes
- (2015) Peter J. Barnes JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management
- (2015) Prescott G Woodruff et al. LANCET
- Neutralizing TNFα restores glucocorticoid sensitivity in a mouse model of neutrophilic airway inflammation
- (2015) L Dejager et al. Mucosal Immunology
- Targeting the IL-17–TH17 pathway
- (2015) Hilary S. Bartlett et al. NATURE REVIEWS DRUG DISCOVERY
- Canakinumab for the treatment of chronic obstructive pulmonary disease
- (2015) Paola Rogliani et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary disease
- (2015) Osama Eltboli et al. RESPIROLOGY
- NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases
- (2015) Amna Abderrazak et al. Redox Biology
- Chronic Obstructive Pulmonary Disease, Neutrophils and Bacterial Infection: A Complex Web Involving IL-17 and IL-22 Unravels
- (2015) Dave Singh EBioMedicine
- Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease
- (2015) Leena George et al. Therapeutic Advances in Chronic Disease
- Eosinophilic inflammation in COPD: prevalence and clinical characteristics: Table 1–
- (2014) Dave Singh et al. EUROPEAN RESPIRATORY JOURNAL
- Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system
- (2014) L. Guilleminault et al. JOURNAL OF CONTROLLED RELEASE
- IL-5 Triggers a Cooperative Cytokine Network That Promotes Eosinophil Precursor Maturation
- (2014) Patricia C. Fulkerson et al. JOURNAL OF IMMUNOLOGY
- Adverse reactions to biologic agents and their medical management
- (2014) Onur Boyman et al. Nature Reviews Rheumatology
- Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study
- (2014) Christopher E Brightling et al. Lancet Respiratory Medicine
- Genetic deletion of IL-17A reduces cigarette smoke-induced inflammation and alveolar type II cell apoptosis
- (2013) Ying Chang et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Cellular and Molecular Mechanisms of Chronic Obstructive Pulmonary Disease
- (2013) Peter J. Barnes CLINICS IN CHEST MEDICINE
- Expression of Interleukin (IL)-10, IL-17A and IL-22 in Serum and Sputum of Stable Chronic Obstructive Pulmonary Disease Patients
- (2013) Li Zhang et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers
- (2013) A. Kirsten et al. EUROPEAN RESPIRATORY JOURNAL
- Comparison of TNF antagonism by etanercept and dexamethasone on airway epithelium and remodeling in an experimental model of asthma
- (2013) Ozge Yilmaz et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- New anti-inflammatory targets for chronic obstructive pulmonary disease
- (2013) Peter J. Barnes NATURE REVIEWS DRUG DISCOVERY
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
- (2013) Xin Yao et al. PHARMACOLOGY & THERAPEUTICS
- p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD
- (2012) Audreesh Banerjee et al. CURRENT OPINION IN PHARMACOLOGY
- Emerging anti-inflammatory strategies for COPD
- (2012) Mario Cazzola et al. EUROPEAN RESPIRATORY JOURNAL
- Role of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases
- (2012) Mercedes Rincon et al. International Journal of Biological Sciences
- The Discovery, Engineering and Characterisation of a Highly Potent Anti-Human IL-13 Fab Fragment Designed for Administration by Inhalation
- (2012) Daniel Lightwood et al. JOURNAL OF MOLECULAR BIOLOGY
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
- (2012) Alvar Agustí et al. PLoS One
- TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial
- (2012) Shawn D Aaron et al. THORAX
- Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation
- (2012) Erik Bathoorn et al. International Journal of Chronic Obstructive Pulmonary Disease
- IL-17 in chronic obstructive pulmonary disease
- (2012) Mario Cazzola et al. Expert Review of Respiratory Medicine
- Systemic Manifestations of COPD
- (2011) Yvonne Nussbaumer-Ochsner et al. CHEST
- Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice
- (2011) Ning Shen et al. INHALATION TOXICOLOGY
- Activation of WNT / β-Catenin Signaling in Pulmonary Fibroblasts by TGF-β1 Is Increased in Chronic Obstructive Pulmonary Disease
- (2011) Hoeke A. Baarsma et al. PLoS One
- IL-1α/IL-1R1 Expression in Chronic Obstructive Pulmonary Disease and Mechanistic Relevance to Smoke-Induced Neutrophilia in Mice
- (2011) Fernando M. Botelho et al. PLoS One
- The Cytokine Network in Chronic Obstructive Pulmonary Disease
- (2009) Peter J. Barnes AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Role for Interleukin-6 in COPD-Related Pulmonary Hypertension
- (2009) Ari Chaouat et al. CHEST
- T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients
- (2009) A. Di Stefano et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
- (2009) Alexander U. Lüthi et al. IMMUNITY
- Genome-Wide Comparison between IL-17A- and IL-17F-Induced Effects in Human Rheumatoid Arthritis Synoviocytes
- (2009) S. Zrioual et al. JOURNAL OF IMMUNOLOGY
- TNF-α inhibitors in asthma and COPD: We must not throw the baby out with the bath water
- (2009) Maria Gabriella Matera et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Tc2 Response at the Onset of COPD Exacerbations
- (2008) Demosthenes Makris et al. CHEST
- Interaction of TGF-β with Immune Cells in Airway Disease
- (2008) Benjamin Moore et al. CURRENT MOLECULAR MEDICINE
- TNF-α antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease
- (2007) Samy Suissa et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search